BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹148 Cr | ₹130 Cr | ₹90 Cr | ₹86 Cr | ₹71 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹148 Cr |
Mar2023 | ₹130 Cr |
Mar2022 | ₹90 Cr |
Mar2021 | ₹86 Cr |
Mar2020 | ₹71 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹148 Cr | 13.97 | |
Mar2023 | ₹130 Cr | 43.75 | |
Mar2022 | ₹90 Cr | 4.25 | |
Mar2021 | ₹86 Cr | 21.68 | |
Mar2020 | ₹71 Cr | - |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹202.6 Cr | -4.5% | -5.4% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -4.5% |
-5.4% |
0.8% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses